NanoComposix specializes in the development and scaled manufacturing of nanoparticle-enabled solutions for diagnostics and therapeutics. Our CRO and CMO services support projects from feasibility through clinical studies and cGMP manufacturing with extensive scientific expertise in systems utilizing gold, silica, and polymer nanoparticles.
nanoComposix is a fully owned subsidiary of Fortis Life Sciences